Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Multicenter, Randomized, Double-blind, Multiple-dose, Adaptive, Placebo- and Active-controlled Study of TRV130 for the Treatment of Acute Postoperative Pain After Bunionectomy

Next Previous
Search
Trial Profile

A Phase 2, Multicenter, Randomized, Double-blind, Multiple-dose, Adaptive, Placebo- and Active-controlled Study of TRV130 for the Treatment of Acute Postoperative Pain After Bunionectomy

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 16 Sep 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oliceridine (Primary) ; Morphine
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Trevena

    • Most Recent Events

    • 07 Feb 2018 Results of pooled data from six phase 1 and phase 2 trial assessing population pharmacokinetic/pharmacodynamic (PK/PD) model of the PK and PD of oliceridine, were published in the Journal of Clinical Pharmacology.
    • 17 Oct 2016 According to Trevena media release, the company will webcast and present data at the Annual Meeting of the American Society of Anesthesiologists 2016.
    • 14 May 2016 Results of two phase II studies evaluating early reduction in pain intensity, presented at the 35th Annual Scientific Meeting of the American Pain Society

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top